Overview
Status
Active
Registry date
2015-07-17
Share capital
5 000,00 PLN
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Sylwia Brzózka – Vice President of the Management Board
Tomasz Lipiński – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sylwia Brzózkaage 37 | 50 | $675.31 | 50% |
Tomasz Lipińskiage 39 | 50 | $675.31 | 50% |
Beneficial owners
No beneficial owners recorded for the company Biosyngen Poland.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Proper Medical Writingsp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
FAQ
The main business activity of Biosyngen Poland focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on July 17, 2015.
The headquarters is located at: ul. Łucka 20, 00-845 Warszawa.
The management board consists of: Sylwia Brzózka (Vice President of the Management Board) and Tomasz Lipiński (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-13